French Tycoon Vincent Bolloré to Stand Trial Over African Ports Corruption Allegations

French industrialist Vincent Bolloré is set to appear before the Paris criminal court in December in the high-profile “African ports” case, facing charges of corruption of foreign public officials and aiding and abetting breach of trust. The case centers on the 2010 presidential campaigns in Togo and Guinea, where investigators…

At Least 48 Young Men Die in South African Initiation Ceremonies Amid Calls for Greater Oversight

At least 48 boys and young men have died during recent initiation ceremonies in South Africa, highlighting persistent dangers in traditional rites of passage. Among the victims was 22-year-old Lamkelo Mtyho, who entered a registered initiation school in good health but never returned home. Mtyho participated in the customary ritual,…

Trump Slams NATO Allies as “Cowards” Over Strait of Hormuz Support Amid U.S.-Israel War on Iran

President Donald Trump on Friday sharply criticized NATO allies for what he called their insufficient support of the U.S.-Israel war against Iran, labeling longstanding allies as “cowards” in a pointed social media post. “Without the U.S.A., NATO IS A PAPER TIGER!” Trump wrote, accusing allied nations of failing to assist…

ODM Leader Oburu Oginga Defends President Ruto Amid Criticism Over Political Remarks

Kisumu, Kenya – The Orange Democratic Movement (ODM) party leader, Dr. Oburu Oginga, has come to the defence of President William Ruto, dismissing criticism that the Head of State’s recent public remarks against opposition figures were unpresidential. Speaking during Idd-ul-Fitr celebrations at Kisumu State Lodge on Friday, Oburu argued that…

Low-Cost Generic Weight-Loss Drugs Set to Expand Global Access as India Patent Expires

A wave of low-cost generic weight-loss drugs is poised to reshape the global fight against obesity following the expiry of a key patent for semaglutide in India on Friday. The development is expected to significantly expand access to treatments previously considered unaffordable for many, particularly in middle-income countries. Semaglutide, the…